Skip to content
Review

Microbial Glucosamine Production: Current Strategies, Process Bottlenecks, and Future Perspectives.

Jul 2026 · Letters in Applied Microbiology · Vol 79 · 0 citations
Medicine

TL;DR

While microbial production of glucosamine offers clear environmental and economic advantages, their large-scale feasibility depends on addressing these challenges through integrated approaches, including CRISPR-based gene editing and metabolic engineering and process optimization.

Abstract

Glucosamine and its derivatives have been extensively used in the nutraceutical, cosmetic, food and pharmaceutical industries. Commercial glucosamine production traditionally relies on the acid or enzymatic hydrolysis of crustacean shells, particularly those of shrimp and crabs. However, these processes are often associated with high production costs, environmental concerns, extensive chemical usage, and the generation of hazardous waste. In recent years, microbial production of glucosamine has emerged as a sustainable and environmentally friendly alternative, offering advantages such as milder processing conditions, reduced chemical inputs, and improved process scalability. Microbial approaches include direct glucosamine biosynthesis by native microorganisms, bioconversion of chitin-rich substrates by chitinolytic microbes, and metabolic engineering of recombinant strains for enhanced production. This review explores microbial approaches for glucosamine production, including direct biosynthesis, chitin bioconversion, and recombinant microbial systems. Key challenges related to substrate utilization, process scalability, strain stability, and product recovery are critically evaluated, along with emerging solutions involving metabolic engineering and process optimization. Additionally, strategies to overcome such challenges such as CRISPR-based gene editing, optimization of culture and fermentation conditions etc. have been discussed. This review emphasizes the fact that while microbial production of glucosamine offers clear environmental and economic advantages, their large-scale feasibility depends on addressing these challenges through integrated approaches.

View source

Similar papers

Review Open access Sep 2026

Biotechnological Advances in Microbial Kojic Acid Production and Sustainable Industrial Applications

Kojic acid is an industrially important fungal secondary metabolite widely utilised in the cosmetic, pharmaceutical, and food industries due to its tyrosinase inhibitory, antioxidant, and metal-chelating properties. The increasing commercial demand for naturally derived kojic acid is constrained by limitations associat...

Parth Shroff, Darshan Marjadi · 0 citations
Review Open access Aug 2026

Xylitol Biomanufacturing: Production Technologies, Industrial Applications and Future Opportunities

Xylitol is a five-carbon sugar alcohol widely used in the food, pharmaceutical, oral healthcare, and personal care industries because of its low caloric value, low glycaemic index, and non-cariogenic properties. Industrial production is mainly based on catalytic hydrogenation of xylose, which provides high conversion e...

Yanjie Jia, Wanting Yang, Lulu Zhang et al. · 1 citation
Review Open access Aug 2026

Harnessing yeast for polyhydroxyalkanoates (PHAs) production: Challenges, engineering strategies, and future prospects.

This review provides the current state of PHAs production from wild yeast strains and the various approaches that have been used to improve yield, and discusses the performance, challenges, and limitations of various synthetic biology and metabolic engineering strategies in yeast strains for PHAs production.

K. Mohanrasu, R. Selvakumar, I. Grainge et al. · 0 citations
Review Open access Aug 2026

Microbial Production of Alternative Proteins for Food Applications: Advances, Industrial Challenges, and Regulatory Status.

The escalating global population and the environmentally inefficient nature of livestock-based protein production are intensifying demand for sustainable and scalable protein alternatives. Microbial biosynthesis, employing engineered cell factories, represents a pivotal strategy for producing functional proteins with a...

Zewei Lu, Zhuoer Chen, Dianqi Yang et al. · 0 citations
Review Open access Sep 2026

Strategic selection of microbial cell factories for sustainable and application-specific terpenoid production

Terpenoids (isoprenoids) constitute one of the largest and most structurally diverse families of natural products with application ranging from flavors, pharmaceuticals to biofuels. Conventional extraction from plants is often limited by low yields, seasonal variability, and environmental constraints; whereas, chemical...

Vibha Shukla, V. Shukla, Shweta Rawat et al. · 0 citations
Review Jul 2026

Metabolic engineering strategies: utilizing different microbial strains and advanced technologies for the synthesis of high-valued terpenoids

Artificial intelligence (AI) and machine learning (ML) have emerged as powerful tools for metabolic engineering by enabling pathway prediction, metabolic flux optimization, enzyme engineering, and identification of bottlenecks throughout terpenoid biosynthesis.

Aakash Kamalesan, K. Kumar, Bharathi Nathan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.